Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8cyclopia sequence 6Prostatic Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Hematologic Diseases 2Head and Neck Neoplasms 2Fatigue 2Warts 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Intraepithelial Neoplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Papilloma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuromyelitis Optica 1Myelitis, Transverse 1Myelitis 1Melanoma 1

Interventions

Tamoxifen 10Specimen Handling 5Chemotherapy, Adjuvant 5Radiotherapy 3Mastectomy, Segmental 3Anastrozole 3Simvastatin 2telapristone acetate 1ruxolitinib 1exemestane 1abemaciclib 1Vinorelbine 1Trastuzumab 1Telemedicine 1Tablets 1Surgical Procedures, Operative 1Sugars 1Starch 1Soybean Proteins 1Radiation Dose Hypofractionation 1Radiation 1Protons 1Proton Therapy 1Probiotics 1Pharmacogenomic Testing 1Omacor 1Neoadjuvant Therapy 1Naltrexone 1Mastectomy, Subcutaneous 1Lovastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Breast Carcinoma In Situ × Sugars × Clear all
NCT02137252 2021-11-16

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡